Analysis of Loss of Heterozygosity in Small Adenocarcinomas of the Lung

Japanese Journal of Clinical Oncology

Volumn 28, Issue 4, 1998, Pages 240-244

  Yoshioka, Hiromu ^a,b,c   Takeuchi, Tomoyo ^d   Matsuno, Yoshihiro ^a   Yamada, Tesshi ^a   Shimosato, Yukio ^b   Hirohashi, Setsuo ^a   Noguchi, Masayuki ^d  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Adenocarcinoma; Early cancer; Genetic alterations; Lung

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER STAGING; CHROMOSOME 17; GENETICS; HETEROZYGOSITY LOSS; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; LUNG TUMOR; PATHOLOGY;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; CHROMOSOMES, HUMAN, PAIR 17; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; NEOPLASM STAGING;

EID: 0032039342     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.4.240     Document Type: Article

References (23)

1. Gazzeri S, Branbilla E, Fromentel CC, Gouyer V, Moro D, Perron P, et al. p53 genetic abnormalities and myc activation in human lung carcinoma. Int J Cancer 1994;58:24-32.
2. Gazzeri S, Brambilla E, Jacrot M, Chauvin C, Benabid AL, Brambilla C. Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice. Cancer Res 1991;51:2566-71.
3. Johnson BE, Kelley MJ Overview of genetic and molecular events in the pathogenesis of lung cancer. Chest 1993;103:1s-3s.
4. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1990;5:1037-43.
5. Iggo R, Gatter K, Bartek J, Lane D, Harris AL Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-9.
6. Bodner SM, Minna JD, Jensen SM, Amico DD, Carbone D, Mitsudomi T, et al. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 1992;7:743-9.
7. Miller CW, Simon K, Aslo A, Kok K, Yokota J, Koeffler HP, et al. p53 mutations in human lung tumors. Cancer Res 1992;52:1695-8.
8. Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R. Retinoblastoma protein expression in lung cancer: an immunohistochemical analysis. Oncology 1994;51:544-51.
9. Xu HJ, Hu SX, Cagle PT, Moore GE, Benedict WF. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res 1991;51:2735-9.
10. Shiseki M, Kohno T, Nishikawa R, Samashima Y, Mizoguchi H, Yokota J. Frequent allelic losses on chromosomes 2q, 18q and 22q in advanced non-small cell lung carcinoma. Cancer Res 1994;54:5643-8.
11. Yokota J, Wada M, Shimosato Y, Terada M, Sugimura T. Loss of heterozygosity on chromosomes 3, 13 and 17 in small-cell carcinoma and on chromosome 3 in adenoccarcinoma of the lung Proc Natl Acad Sci USA 1987;84:9252-6
12. Wieland H, Bòhm M. Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer. Cancer Res 1994;54:1772-4.
13. Merlo A, Gabrielson E, Askin F, Sidransky D. Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 1994;54:640-2.
14. Sato S, Nakamura Y, Tsuchiya E. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 1994;54:5652-5.
15. Fong KM, Zimmerman PV, Smith PJ. Correlation of loss of heterozygosity at 11p with tumor progression and survival in non-small cell lung cancer. Genes Chromosomes Cancer 1994;10:183-9.
16. Ludwig CU, Raefle G, Dalquen P, Stulz P, Stahel R, Obrecht JP. Allelic loss on the short arm of chromosome 11 in non-small-cell lung cancer. Int J Cancer 1991;49:661-5.
17. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer 1995;75:2844-52.
18. Zhuang Z, Memo MJ, Chuaqui R, Liotta LA, Emmert-Buck MR. Identical allelic loss on chromosome 11q13 in microdissected in situ and invabive human breast cancer. Cancer Res 1995;55:467-71.
19. Shibata D. Extraction of DNA from paraffin-embedded tissue for analysis by polymerase chain reaction New tricks from an old friend. Hum Pathol 1994;25:561-3.
20. Jones MH, Nakamura Y. Detection of loss of heterozygosity at the human TP53 locus using a dmucleotide repeat polymorphism. Genet Chromosomes Cancer 1992;5:89-90.
21. Noguchi M, Hirohashi S. Cell lines from nonneoplastic liver and hepatocellular carcinoma tissue from a single patient. In Vitro Cell Dev Biol 1996;32:135-7.
22. Hauge XY, Litt M. A study of the origin of shadow bands seen when typing dinucleotide repeat polymorphisms by the PCR. Hum Mol Genet 1993;2:411-15.
23. Litt M, Hauge X, Sharma V. Shadow bands seen when typing polymorphic dinucleotide repeats: some causes and cures Biotechniques 1993;15:280-4.